Loading color scheme

Dr. Yang Liu Acknowledged as Top 20 Dynamic CEOs of 2022
01 April 2022

Dr. Yang Liu Acknowledged as Top 20 Dynamic CEOs of 2022

Category: News Releases

ROCKVILLE, Md., Mar. 31, 2022 - The CEO Publication, a unique digital platform featuring the industry experts who have created ripples across various areas of expertise, has acknowledged Dr. Yang Liu, Chairman, CEO & CSO, OncoC4 — a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment — one among the “Top 20 Dynamic CEOs of 2022″ who is transforming the industry with his unique solutions. The CEO Publication has become a pioneering magazine owing to their unique coverage of news, articles & industry leaders concentrating on transforming various arenas.

Owing to the innovative approach adopted by Dr. Yang Liu and OncoC4 developing unique drugs that uncouple therapeutic effects and immunotherapy-related adverse effects, Dr. Liu is being featured in the “Top 20 Dynamic CEOs of 2022″ edition. Adam Patrick, Managing Editor of The CEO Publication, says, “Dr. Yang Liu’s love of science and appreciation of others’ talents attract a diverse team of successful business, clinical and regulatory executives, and biopharmaceutical researchers and inspire the team to work together, hence he is being featured as one of the Top 20 Dynamic CEOs of 2022 who is a true inspiration.”

Full article can be found here: "Leading with Research & Innovation | Dr. Yang Liu"